Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of 131 I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study

Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of 131 I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study

Saved in:
Bibliographic Details
Published in:The journal of clinical endocrinology and metabolism Vol. 96; no. 5; pp. 1368 - 1376
Main Authors: Graf, H., Fast, S., Pacini, F., Pinchera, A., Leung, A., Vaisman, M., Reiners, C., Wemeau, J. L., Huysmans, D., Harper, W., Driedger, A., de Souza, H. Noemberg, Castagna, M. G., Antonangeli, L., Braverman, L., Corbo, R., Düren, C., Proust-Lemoine, E., Edelbroek, M. A., Marriott, C., Rachinsky, I., Grupe, P., Watt, T., Magner, J., Hegedus, L.
Format: Journal Article
Language:English
Published: 01-05-2011
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0021-972X
1945-7197
DOI:10.1210/jc.2010-1193